Two New CBD Bills Introduced in Indiana Legislature


Indiana (D) Rep. Clyde Kersey and (R) Sen. Brandt Hershman each filed a bill on Tuesday meant to legalize and protect the medicinal use of the marijuana plant’s CBD cannabinoid for residents of the Hoosier State.

If passed, Rep. Kersey’s House Bill 1177 would allow use of the non-psychoactive CBD (cannabidiol) oil as treatment for epilepsy. And, providing some much-needed legal cover, Sen. Hershman’s Senate Bill 327 would provide an affirmative defense against prosecution for the medicinal use of the beneficial cannabinoid.

While the 2016 Indiana General Assembly failed to advance a single piece of medical marijuana legislation for their constituents, an October 2016 poll found 73% of those surveyed support the idea of cultivating an effectual medical marijuana program.

WTHR - Howey Politics Indiana Poll

WTHR – Howey Politics Indiana Poll

House Bill 1177:

“Cannabidiol oil treatment for epilepsy. Provides that an individual who possesses or uses cannabidiol oil for the treatment of intractable epilepsy is not subject to criminal penalties for the possession or use of the cannabidiol oil if certain conditions are met. Provides civil, criminal, and administrative immunity for a physician who recommends, possesses, dispenses, or administers cannabidiol oil in the treatment of intractable epilepsy.”

Senate Bill 327:

“Medicinal use of cannabidiol. Defines “cannabidiol”, and provides an affirmative defense to possession of cannabidiol if the person or the person’s child has been diagnosed with certain medical conditions, the cannabidiol contains no THC, and other specified conditions are met.”

Despite several attempts by Indiana’s lawmakers to advance any meaningful cannabis policy during the 2016 legislative session, residents are currently prohibited from utilizing any of the plant’s medicinal compounds. In the hopes of avoiding another missed opportunity, we at encourage Indiana’s residents to speak up and let your representatives know … you strongly support medical marijuana legislation.

Also working towards a slightly more common sense approach with regards to medicinal cannabis, Indiana’s vets have produced the below PSA in the hopes of educating fellow Hoosiers on the importance of passing effectual MMJ legislation in the next legislative session.

About Author

Born in Long Beach, raised on the central coast: I surf, dab, burn, and blog – though not necessarily in that order. I'm a husband, a father and a lifelong consumer of connoisseur grade weed. I don't drink alcohol or consume any other "drugs." I consider myself to be living proof that weed is not a gateway drug. If it were, I'd be in some serious trouble. Instead, as a 50-year-old ex-realtor that has been smoking weed for nearly 80% of my life (just did the math) ... I can only say, marijuana is safer than prescription pills or alcohol could ever hope to be for calming what stirs the savage beast.


    • @Tom

      Hopefully, all adults will vote their conscience – compelling their local lawmakers to truly represent their constituents. As to the families with children who currently suffer from epilepsy in the state of Indiana, I suggest an exodus to any of the states that have already reformed their marijuana laws.

    • @Chris, Agreed.
      As long as the feds keep marijuana categorized as a schedule I narcotic, politicians will be able to deploy the old dogmatic argument, that marijuana is somehow harmful. Ignoring the research done on the CBD cannabinoid and embracing the rhetoric of the drug war, lawmakers around the country are forcing families to flee for those more advanced states that have embraced the science behind medical marijuana.

  1. I found this article from a cancer institute, here is the article.

    Pediatric cancer: Survey finds strong support among clinicians for medical marijuana use in children with cancer

    Prasanna Ananth, MD, MPH
    Abstract 10581: Prasanna Janaki Ananth, MD, MPH – Presenter
    Poster Board: #272
    Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Poster Session, Pediatric Oncology, Monday, June 6, 8 a.m. – 11:30 a.m. Hall A

    More than 90 percent of pediatric oncology providers favored access to medical marijuana for children and adolescents with cancer, according to a survey study to be presented at the ASCO annual meeting.

    With more states legalizing medical marijuana, patients and families are asking providers to help them obtain marijuana products to try as treatments for nausea, pain, and loss of appetite. Nearly one-third of respondents to the survey reported receiving such requests more than once in the past month, according to lead researcher Prasanna Ananth, MD, MPH, pediatric oncologist, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Senior author is Joanne Wolfe, MD, MPH, director of the Pediatric Advanced Care Team, a joint pediatric palliative care program of Dana-Farber Cancer Institute and Boston Children’s Hospital.

    The study surveyed clinicians in Illinois, Massachusetts, and Washington, where medical marijuana is legal. Of 301 respondents, 92 percent favored helping pediatric cancer patients obtain medical marijuana. A majority – 88 percent – said using the drug near the end of life was appropriate, but only 34 percent would favor its use in early stage cancer treatment.

    A marijuana-derived synthetic drug, dronabinol (Marinol) is routinely used in supportive cancer care to prevent or treat nausea and vomiting and to stimulate appetite. Patients anecdotally say medical marijuana, whether smoked or taken as an oil, is helpful for these problems, but its effectiveness hasn’t been compared to dronabinol or other drugs taken to combat nausea, say the authors. Ananth and Wolfe say they plan to conduct a second survey seeking opinions from adolescent and young adult patients and their parents about medical marijuana use.

Leave A Reply